ATE528307T1 - Imidazopyridin-2-onderivate als inhibitoren von endothellipase - Google Patents

Imidazopyridin-2-onderivate als inhibitoren von endothellipase

Info

Publication number
ATE528307T1
ATE528307T1 AT07723584T AT07723584T ATE528307T1 AT E528307 T1 ATE528307 T1 AT E528307T1 AT 07723584 T AT07723584 T AT 07723584T AT 07723584 T AT07723584 T AT 07723584T AT E528307 T1 ATE528307 T1 AT E528307T1
Authority
AT
Austria
Prior art keywords
alkyl
cycloalkyl
aryl
bicyclic
ocoa
Prior art date
Application number
AT07723584T
Other languages
English (en)
Inventor
Gerhard Zoller
Stefan Petry
Markus Follmann
Guenter Mueller
Norbert Tennagels
Original Assignee
Sanofi Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Sa filed Critical Sanofi Sa
Application granted granted Critical
Publication of ATE528307T1 publication Critical patent/ATE528307T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
    • A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AT07723584T 2006-03-28 2007-03-26 Imidazopyridin-2-onderivate als inhibitoren von endothellipase ATE528307T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102006014685A DE102006014685A1 (de) 2006-03-28 2006-03-28 Imidazo-pyridin-2-on-derivate als Inhibitoren von Lipasen und Phospholiphasen
PCT/EP2007/002637 WO2007110215A1 (en) 2006-03-28 2007-03-26 Imidazopyridin-2-one derivatives as inhibitors of endothelial lipase

Publications (1)

Publication Number Publication Date
ATE528307T1 true ATE528307T1 (de) 2011-10-15

Family

ID=38179814

Family Applications (1)

Application Number Title Priority Date Filing Date
AT07723584T ATE528307T1 (de) 2006-03-28 2007-03-26 Imidazopyridin-2-onderivate als inhibitoren von endothellipase

Country Status (14)

Country Link
US (1) US7897616B2 (de)
EP (1) EP2001878B1 (de)
JP (1) JP2009531356A (de)
KR (1) KR20080104341A (de)
CN (1) CN101405288A (de)
AT (1) ATE528307T1 (de)
AU (1) AU2007229708A1 (de)
BR (1) BRPI0709211A2 (de)
CA (1) CA2647422A1 (de)
DE (1) DE102006014685A1 (de)
MX (1) MX2008012126A (de)
NO (1) NO20084419L (de)
TW (1) TW200815434A (de)
WO (1) WO2007110215A1 (de)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2025674A1 (de) 2007-08-15 2009-02-18 sanofi-aventis Substituierte Tetrahydronaphthaline, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
TW201014822A (en) 2008-07-09 2010-04-16 Sanofi Aventis Heterocyclic compounds, processes for their preparation, medicaments comprising these compounds, and the use thereof
EP2351744B1 (de) 2008-10-17 2015-01-07 Shionogi & Co., Ltd. Essigsäureamidderivat mit hemmender wirkung auf vaskuläre endothellipase
WO2011034741A1 (en) * 2009-09-15 2011-03-24 Merck Sharp & Dohme Corp. Imidazopyridin-2-one derivatives
KR20120092141A (ko) * 2009-10-29 2012-08-20 서트리스 파마슈티컬즈, 인코포레이티드 시르투인 조절제로서의 비시클릭 피리딘 및 유사체
CA2784710A1 (en) * 2009-12-15 2011-06-23 Shionogi & Co., Ltd. Oxadiazole derivative having endothelial lipase inhibitory activity
US8933024B2 (en) 2010-06-18 2015-01-13 Sanofi Azolopyridin-3-one derivatives as inhibitors of lipases and phospholipases
JP2013538215A (ja) 2010-08-31 2013-10-10 エスエヌユー アールアンドディービー ファウンデーション ＰＰＡＲδアゴニストの胎児再プログラミング用途
US9493412B2 (en) 2011-09-27 2016-11-15 Bristol-Myers Squibb Company Pyrrolinone carboxamide compounds useful as endothelial lipase inhibitors
WO2013049096A1 (en) 2011-09-27 2013-04-04 Bristol-Myers Squibb Company Pyrrolinone carboxamide compounds useful as endothelial lipase inhibitors
EP2760829B1 (de) 2011-09-27 2016-05-18 Bristol-Myers Squibb Company Pyrrolinon-carboxamid-derivate als inhibitoren von endothellipase
WO2013049104A1 (en) 2011-09-30 2013-04-04 Bristol-Myers Squibb Company Pyridinedione carboxamide inhibitors of endothelial lipase
WO2013048930A1 (en) 2011-09-30 2013-04-04 Bristol-Myers Squibb Company Pyridinedione carboxamide inhibitors of endothelial lipase
EP2760840B1 (de) 2011-09-30 2015-08-12 Bristol-Myers Squibb Company Chinolinon-carboxamid-inhibitoren der endothelialen lipase
WO2013151923A1 (en) 2012-04-03 2013-10-10 Bristol-Myers Squibb Company Pyrimidinone carboxamides as inhibitors of endothelial lipase
US9199946B2 (en) 2012-04-03 2015-12-01 Bristol-Myers Squibb Company Pyrimidinone carboxamide inhibitors of endothelial lipase
EP2870152B1 (de) 2012-07-09 2016-09-28 Bristol-Myers Squibb Company Amid- oder harnstoff-substituierte benzothiazolderivate als inhibitoren von endothellipase
AR092854A1 (es) 2012-07-09 2015-05-06 Bristol Myers Squibb Co Benzotiazoles que contienen sulfonilo como inhibidores de la lipasa endotelial
AR093281A1 (es) 2012-07-19 2015-05-27 Bristol Myers Squibb Co Benzotiazoles ligados a amida, urea o sulfonamida como inhibidores de la lipasa endotelial
WO2014042939A1 (en) 2012-09-11 2014-03-20 Bristol-Myers Squibb Company Ketone linked benzothiazole inhibitors of endothelial lipase
US10173991B2 (en) 2014-01-07 2019-01-08 Bristol-Myers Squibb Company Sulfone amide linked benzothiazole inhibitors of endothelial lipase
US10597370B2 (en) 2016-06-06 2020-03-24 Bristol-Myers Squibb Company 2-(benzothiazol-2-yl)-2-cyano-acetamide derivatives and their use as endothelial lipase inhibitors

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE422799B (sv) * 1975-05-28 1982-03-29 Merck & Co Inc Analogiforfarande for framstellning av 1,3-dihydroimidazo (4,5-b)pyridin-2-oner
US20020128232A1 (en) * 2000-10-12 2002-09-12 Henderson Scott A. Heterocyclic angiogenesis inhibitors
DE102004005172A1 (de) * 2004-02-02 2005-08-18 Aventis Pharma Deutschland Gmbh Indazolderivate als Inhibitoren der Hormon Sensitiven Lipase
CA2565803A1 (en) * 2004-05-28 2006-03-02 Weiguo Liu Benzoureas having anti-diabetic activity
US8138177B2 (en) * 2005-03-15 2012-03-20 Pfizer Inc. Benzimidazolone derivatives as CB2 receptor ligands
DE102005026762A1 (de) * 2005-06-09 2006-12-21 Sanofi-Aventis Deutschland Gmbh Azolopyridin-2-on-derivate als Inhibitoren von Lipasen und Phospholipasen

Also Published As

Publication number Publication date
JP2009531356A (ja) 2009-09-03
EP2001878B1 (de) 2011-10-12
CA2647422A1 (en) 2007-10-04
US20090076068A1 (en) 2009-03-19
WO2007110215A1 (en) 2007-10-04
MX2008012126A (es) 2008-10-03
DE102006014685A1 (de) 2007-10-04
US7897616B2 (en) 2011-03-01
CN101405288A (zh) 2009-04-08
NO20084419L (no) 2008-11-26
TW200815434A (en) 2008-04-01
BRPI0709211A2 (pt) 2011-06-28
EP2001878A1 (de) 2008-12-17
KR20080104341A (ko) 2008-12-02
AU2007229708A1 (en) 2007-10-04

Similar Documents

Publication Publication Date Title
ATE528307T1 (de) Imidazopyridin-2-onderivate als inhibitoren von endothellipase
PE20120120A1 (es) DERIVADOS DE 2H-PIRAZOLO[3,4-d]PIRIMIDINA-4,6(5H,7H)-DIONA, COMO INHIBIDORES DE PDE1
SG151260A1 (en) 5-substituted-2-phenylamino-benzamides as mek inhibitors
DE602006004865D1 (de) Antimykotische mittel
PE20091573A1 (es) Derivados heterociclicos de urea como inhibidores de adn girasa y/o topoisomerasa
PE20080906A1 (es) Derivados heteroarilo como inhibidores de citocina
SI2834239T1 (en) Heterobicyclic compounds as inhibitors of beta-lactamase
PE20061124A1 (es) Compuestos y derivados de dibencil amina
ATE432259T1 (de) Pyridinderivate als dipeptedyl-peptidase-hemmer
PE20091201A1 (es) AMIDAS SUSTITUIDAS COMO INHIBIDORES DE LA TIROSINA QUINASA DE BRUTON (Btk)
ATE360631T1 (de) Azabicyclische heterocyclen als modulatoren des cannabinoidrezeptors
TNSN05069A1 (fr) Derives de la quinolyl propyl piperidine et leur utilisation en tant qu'agents antimicrobiens
HRP20080052T3 (en) Imidazopyridine substituted tropane derivatives with ccr5 receptor antagonist activity for the treatment of hiv and inflammation
MX2008013836A (es) Derivados de 2-piridona para el tratamiento de enfermedades o condiciones en las cuales es benefica la inhibicion de la actividad de elastasa de neutrofilos.
TW200640879A (en) Amide derivatives
PE20061394A1 (es) Metabolitos de n-(2-cloro-6-metilfenil)-2-[[6-[4-(2-hidroxietil)-1-piperazinil]-2-metil-4-pirimidinil]amino]-5-tiazolcarboxamidas
HRP20090264T1 (en) Phenyl-piperazin methanone derivatives
NZ612544A (en) Heterocyclic compounds suitable for the treatment of dyslipidemia
DE602005027677D1 (de) 1,3,4-oxadiazol-2-one als ppar-delta-modulatoren und deren verwendung
TW200728291A (en) Amide derivatives
PE20080207A1 (es) DERIVADOS DE 1-N-AMINO-2-IMIDAZOLIDINONAS COMO INHIBIDORES DEL CANAL DE POTASIO Kv1.5
RU2008108997A (ru) Новое церкоспорамидное производное
ATE388939T1 (de) N-((piperazinyl)hetaryl)arylsulfonamid-derivate mit affinität zum dopamin-d3-rezeptor
BRPI0713311A2 (pt) derivados de pirrolidina tendo atividade no transportador de glyt1
ATE246177T1 (de) Katecholhydrazon-derivate, verfahren zu ihrer herstellung und pharmazeutische zusammensetzungen die diese enthalten

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties